As per Schedule-Y of the Drugs and Cosmetics Rules and Good Clinical Practice Guidelines recognized under the Schedule, mentally challenged and mentally differently able persons, who are incapable of personally giving consent, are considered vulnerable subjects. However, there is no prohibition under the said rules and guidelines that clinical trials cannot be conducted on such patients. For enrolling of such patients in clinical trials, informed consent is required to be obtained from a legally acceptable representative of the patient.
The Government has no proposal to stop drug trials on patients as it considers such trials are vital for establishing safety and efficacy of a new drug and research in the area of drug discovery leading to newer, safer and more efficacious drugs.
_________________________
I added cool smileys to this message... if you don't see them go to: http://s.exps.me
0 comments:
Post a Comment